Dupilumab Efficacy and Safety in Patients with Moderate-to-Severe COPD with Type 2 Inflammation: Pooled Analysis of BOREAS and NOTUS Trials - Bhatt, S; Hoheisel, A; Rabe, K; Hanania, N; Vogelmeier, C; Bafadhel, M; Christenson, S; Papi, A; Laws, E; Akinlade, B; Maloney, J; Lu, X; Bauer, D; Bansal, A; Abdulai, R; Robinson, L (Pneumologie, 2025)